alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 14 (Friday, January 23, 2009)]
[Notices]
[Page 4215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1250]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT

[Docket No. FR-5280-N-03]


Federal Property Suitable as Facilities To Assist the Homeless

AGENCY: Office of the Assistant Secretary for Community Planning and 
Development, HUD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This Notice identifies unutilized, underutilized, excess, and 
surplus Federal property reviewed by HUD for suitability for possible 
use to assist the homeless.

DATES: Effective Date: January 23, 2009.

FOR FURTHER INFORMATION CONTACT: Kathy Ezzell, Department of Housing 
and Urban Development, 451 Seventh Street, SW., Room 7262, Washington, 
DC 20410; telephone (202) 708-1234; TTY number for the hearing- and 
speech-impaired (202) 708-2565 (these telephone numbers are not toll-
free), or call the toll-free Title V information line at 800-927-7588.

SUPPLEMENTARY INFORMATION: In accordance with the December 12, 1988 
court order in National Coalition for the Homeless v. Veterans 
Administration, No. 88-2503-OG (D.D.C.), HUD publishes a Notice, on a 
weekly basis, identifying unutilized, underutilized, excess and surplus 
Federal buildings and real property that HUD has reviewed for 
suitability for use to assist the homeless. Today's Notice is for the 
purpose of announcing that no additional properties have been 
determined suitable or unsuitable this week.

    Dated: January 15, 2009.
Mark R. Johnston,
Deputy Assistant Secretary for Special Needs.
 [FR Doc. E9-1250 Filed 1-22-09; 8:45 am]
BILLING CODE 4210-67-P
Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

Pursuant to 18 U.S.C. § 1350, as created by
Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of ImmunoCellular Therapeutics, Ltd. (the Company) hereby certifies that, to his knowledge:

(i) The Quarterly Report on Form 10-QSB of the Company for the fiscal quarter ended March 31, 2007 (the Report) fully
complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                   |  |  |  |     |  |                                      
|------------------ |  |  |  | --- |  | -------------------------------------
|Date: May 15, 2007 |  |  |  | By: |  | /s/ C. Kirk Peacock                  
|                   |  |  |  |     |  | C. Kirk Peacock                      
|                   |  |  |  |     |  | Chief Financial Officer and Treasurer
U.S. FOREST SERVICE URGES PUBLIC TO CONTACT LAND MANAGERS/OWNERS BEFORE FLYING DRONES TO PREVENT ACCIDENTS 

The U.S. Forest Service is urging members of the public who are planning to fly Unmanned Aircraft Systems (UAS), also known as “drones,” to contact the manager or owner of the land they play to fly over ahead of time to find out whether any agency natural resource management flights are scheduled to prevent accidents. 

	U.S. Forest Service airplanes and helicopters fly regularly over private, state, and National Forest System lands at low altitudes to perform a variety of natural resource management missions. These include aerial surveys to detect forest insect and disease outbreaks, remote sensing to acquire aerial images and data of forests and grasslands, and aerial spraying to control or eradicate major forest pests. Under Federal Aviation Administration (FAA) safety guidelines, members of the public are supposed to fly drones at or below 400 feet. That is about the same altitude at which U.S. Forest Service aircraft often fly to perform natural resource management missions, which creates the potential for an accident. 

	“It would be a real tragedy if a member of the public was flying a drone for fun and either collided with a (U.S. Forest Service or partnering organization, i.e. State Department of Forestry, Agriculture, or Natural Resources; National Aeronautics and Space Administration; U.S. Department of the Interior [DOI or DOI bureau, such as the National Park Service]; Federal Emergency Management Administration; Animal and Plant Health Inspection Service; University, etc.) aircraft or caused a pilot to be distracted and crash, resulting in serious injuries or fatalities,” said (Name), (Title), with the (organization name). “We are asking the public to work with us to help prevent that from happening.”

	The U.S. Forest Service urges members of the public to contact the owner or manager of the land where they want to fly a drone beforehand to see if any natural resource management missions are planned during the time they want to fly and if so, to please plan on flying at another time or location. Contact information for all U.S. Forest Service offices in the U.S. is located at www.fs.fed.us in the “Find a Forest or Grassland” section. Information about partner organization resource operations may be obtained by contacting Forest Health Protection unit Aviation Officers, a list is available at https://www.fs.fed.us/foresthealth/aviation/regionalaviation.shtml Information about U.S. Forest Service natural resource management flights is also available on several websites, including the FAA PilotWeb site https://pilotweb.nas.faa.gov/PilotWeb/http://tfr.faa.gov/tfr_map_ims/html/ and the Defense Internet Notam Service (DINS) https://www.notams.faa.gov/dinsQueryWeb/

### 

.
<PAGE>

                                                                   Exhibit 99.1




                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Angelica Corporation (the "Company") on
Form 10-K for the fiscal year ended January 25, 2003, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Don W.
Hubble, Chairman, President and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     1.  The Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     2.  The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of
         operations of the Company.





                                       /s/ Don W. Hubble
                                       ---------------------------------------
                                       Don W. Hubble
                                       Chairman, President and Chief Executive
                                       Officer of Angelica Corporation

                                       April 22, 2003




A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 HAS BEEN
PROVIDED TO THE COMPANY AND WILL BE RETAINED BY THE COMPANY AND FURNISHED TO THE
SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.
| [ X ] | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|-------|--------------------------------------------------------------------------------------|

|   | [   ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|----------------------|------------------------------------------------------------------------------------------|

| Title of each class | Name of each exchange on which registered |
|---------------------|-------------------------------------------|
| None                | None                                      |

| UNITS OF LIMITED PARTNERSHIP INTEREST(Title of Class)  |
|-------------------------------------------------------------|

----

----

----

| (b)   | Exhibits |
|-----------------|----------|

| 31.1   | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------|

| 31.2   | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------|

| 32.1   | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------|

| 32.2   | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------|

----
Exhibit 10.1
 
  
 Re:
    
    Amendment to Employment Agreement
       IDM Pharma, Inc.
    
    9 Parker, Suite 100
    
    Irvine, CA 92618-1605 USA
    

    TEL. +1.949.470.4751
    

    FAX +1.949.470.6470
    
    www.idm-pharma.com




---



##### 



IDM Pharma, Inc.
 I have read and agree and consent to the foregoing amendments of my employment agreement.
 Dated
    
    10/20/08
    
    
    
    /s/ Robert De VaereRobert De Vaere
Exhibit 31.1
   
 CEO Certification
 
 I, Steve Westlund, certify that:
 
 The undersigned certifies that:
 
 1. I have reviewed this quarterly report on Form 10-QSB of Kaire Holdings, Incorporated. (the "Company");
 
 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; and
 
 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this quarterly report.
 
 4. The Company's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Company and have:
 
 a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
 b) evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
 c) disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting;
 
 5. The Company's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of Company's board of directors (or persons performing the equivalent functions);
 
 a) all significant deficiencies in the design or operation of internal controls which could adversely affect the Company's ability to record, process, summarize and report financial data and have identified for the Company's auditors any material weaknesses in internal controls; and
 
 b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal controls over financial reporting.
 
 Date: December 23, 2003
 
 /s/ Steve Westlund
 Steve Westlund, Chief Executive Officer,
 President, Chief Accounting Officer and Director
DENIED and Opinion Filed March 10, 2023 

# S

In The 

### Court of Appeals Fifth District of Texas at Dallas No. 05-23-00054-CV IN RE Y.C., Relator Original Proceeding from the 397th Judicial District Court Grayson County, Texas Trial Court Cause No. FA-20-1411

MEMORANDUM OPINION Before Justices Reichek, Nowell, and Miskel Opinion by Justice Nowell Before the Court is relator’s Janua ry 19, 2023 petition seeking a writ of mandamus compelling the trial court to v acate its Temporary Orders in Suit to Modify Parent–Child Relations hip dated December 8, 2022. Entitlement to mandamus relief requires re lator to show that the trial court clearly abused its discretion and that rela tor lacks an adequate appellate remedy. In re Prudential Ins. Co. of Am. , 148 S.W.3d 124, 135–36 (Tex. 2004) (orig. proceeding). After reviewing relator’s petiti on and the record before us, we conclude that relator has failed to demonstrate a clear abuse of discretion.–2– Accordingly, we deny the petition for writ of mandamus. See T EX
. R. A PP
. P. 52.8(a).

230054F.P05 /Erin A. Nowell / ERIN A. NOWELL JUSTICE
#### Kathleen Scott et al., Appellants, v General Motors Corporation et al., Respondents, et al., Defendant.

[609 NYS2d 252]

—In an action to recover damages for personal injuries, etc., the plaintiffs appeal from stated portions of an order of the Supreme Court, Queens County (Smith, J.), dated January 13, 1992, which, *inter alia,*denied those branches of their motion which were for leave to serve an amended complaint adding a claim for punitive damages and increasing the ad damnum clause, and for leave to serve an amended bill of particulars.

Ordered that the order is affirmed insofar as appealed from, with costs.

We do not accept the plaintiffs’ contention that the Supreme Court erred in denying their motion to amend certain allegations of the complaint and bill of particulars and increase the ad damnum clause of the complaint to include punitive damages. While it is firmly established that leave to amend a pleading shall be freely granted *(see,*CPLR 3025 [b]), a motion to amend is committed to the broad discretion of the trial court, and the resulting determination will not lightly be set aside *(see, Citrin v Royal Ins. Co.,*172 AD2d 795; *Napoli v Canada Dry Bottling Co.,*166 AD2d 696; *Redco v Town of Oyster Bay,*160 AD2d 984; *Garza v VICO Utils.,*150 AD2d 520).

The proposed factual allegations would add new theories of liability as to the knowledge of the defendant General Motors Corporation of any prior complaints or notice of any defect nine years after the injury, eight years after the commencement of the action, and after the plaintiffs filed a note of issue and withdrew the case from the trial calendar on two occasions.

Additionally, the plaintiffs’ motion was not supported by an affidavit showing the merit of the proposed amendments, nor by any affidavit showing a reasonable excuse for the extensive delay in seeking leave to amend the pleadings. General Motors Corporation would be prejudiced through the assertion of a new theory of liability, *i.e.,*that it had prior notice of a defect, to which Canada Dry Bottling Co. of N. Y. had only conclusorily alluded in the motion *(see, Marks v Radmin,*163 AD2d 368; *Napoli v Canada Dry Bottling Co., supra; Hyper*
      *571
      *tronics Inc. v Digital Equip. Corp.,*159 AD2d 607; *Gallo v Aiello,*139 AD2d 490; *Alexander v Seligman,*131 AD2d 528; *Raies v Apple Annie’s Rest.,*115 AD2d 599).

The case of *Masaki v General Motors Corp.*(71 Haw 1, 780 P2d 566), relied upon by the plaintiffs, is inapposite. Thompson, J. P., Santucci, Friedmann and Florio, JJ., concur.
#### Connor v. Harless

Case below: 176 N.C. App. 402

No. 162P06

Pit’s PDR Under N.C.G.S. § 7A-31 (COA05-355)

Denied 01/25/07

Hudson, J., Recused
<PAGE>

                                                               Exhibit 10.30


                            ANGELICA CORPORATION
                            EMPLOYMENT AGREEMENT
                              SECOND AMENDMENT
                              ----------------

         This Amendment ("Amendment") has been entered into as of the 1st
day of February, 2004, by and between Angelica Corporation, a Missouri
Corporation ("Angelica") and Paul R. Anderegg, an individual ("Employee").

         WHEREAS, Angelica currently employs Employee as Vice President of
Angelica and President of Angelica's Textile Services Business Segment
pursuant to that certain Employment Agreement, dated the 1st day of
February, 2003, as previously amended, (the "Agreement"); and

         WHEREAS, Angelica and Employee wish to continue the employment
relationship between them and to further amend the Agreement as set forth in
this Amendment.

         NOW, THEREFORE, in consideration of the mutual promises herein
contained, the parties hereto agree to amend the Agreement as follows:

         1.   Section 2.1 of the Agreement is hereby amended to read as
              follows:

                  2.1 INITIAL TERM OF AGREEMENT; RENEWAL TERMS. The initial
                  Term of this Agreement shall be for two years commencing
                  on the Effective Date, subject to automatic renewal for
                  one or more additional Terms of one year each commencing
                  immediately upon the end of the initial Term or the
                  then-current renewal Term, as the case may be, unless
                  either party to this Agreement gives a Notice of
                  Non-Renewal to the other party not later than 90 days
                  prior to the end of the initial Term or the then-current
                  renewal Term, as the case may be. In the event that such a
                  Notice of Non-Renewal is given as set forth in this
                  Section 2.1, the Date of Termination will be the last day
                  of the initial Term or the then-current Term, as the case
                  may be.

         2.   Except as otherwise expressly amended by this Amendment, all
              other terms, conditions and covenants of the Agreement, as
              previously amended, shall remain unchanged and in full force
              and effect.

         IN WITNESS WHEREOF, Employee and Angelica, pursuant to the
authorization from its Board, have caused this Amendment to be executed in
its name on its behalf, all as of the day and year first above written.

                                       /s/ Paul R. Anderegg
                                       -------------------------
                                       Paul R. Anderegg


                                       ANGELICA CORPORATION

                                       By: /s/ Stephen M. O'Hara
                                           ---------------------
                                       Name:  Stephen M. O'Hara
                                       Title: President & CEO
----

Exhibit 32.1 

CERTIFICATION PURSUANT TO THE SARBANES-OXLEY ACT 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 
I, John L. Threshie Jr., CEO of The Tirex Corporation (the "Company") dohereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: 

1.   This Quarterly Report on Form 10-QSB of the Company for the period endedSeptember 30, 2006 as filed with the Securities and Exchange Commission (the"report"), fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and 

2.    Theinformation contained in the report fairly presents, in all material respects,the financial condition and results of operations of the Company. 

/s/ John L. Threshie Jr.John L. Threshie Jr., CEO 

Date: November 13, 2006
[Federal Register Volume 74, Number 108 (Monday, June 8, 2009)]
[Notices]
[Pages 27160-27161]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13286]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel; Pain, Morphine and the 
Developing Brain: School Age Outcomes.
    Date: July 2, 2009.
    Time: 12 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Room 5B01, Rockville, MD 20852, Telephone Conference Call).
    Contact Person: Peter Zelazowski, PhD, Scientific Review 
Officer, Division of Scientific Review, Eunice Kennedy Shriver

[[Page 27161]]

National Institute of Child Health and Human Development, NIH, 6100 
Executive Boulevard, Rm. 5B01, Bethesda, MD 20892-7510, 301-435-
6902, <a href="/cdn-cgi/l/email-protection#99e9fcedfcebb7e3fcf5f8e3f6eeeaf2f0d9f7f0f1b7fef6ef"><span class="__cf_email__" data-cfemail="81f1e4f5e4f3affbe4ede0fbeef6f2eae8c1efe8e9afe6eef7">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: June 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-13286 Filed 6-5-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>